By Ms Amanda Dart Roxburgh

Books

Roxburgh AD; Ritter A; Slade T; Burns L, 2014, Trends in Drug Use and Related Harms in Australia, 2001 to 2013, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, http://ndarc.med.unsw.edu.au/resource/trends-drug-use-and-related-harms-australia

Roxburgh AD; Ritter A; Grech K; Slade T; Burns LA, 2011, Trends in Drug Use and Related Harms in Australia, 2001 to 2011, Drug Policy Modelling Program, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, http://ndarc.med.unsw.edu.au/resource/trends-drug-use-and-related-harms-australia-2001-2011-0

Randall D; Roxburgh AD; Gibson AE; Degenhardt LJ, 2009, Mortality among people who use illicit drugs: a toolkit for classifying major causes of death, National Drug and Alcohol Research Centre, Sydney, NSW, http://ndarc.med.unsw.edu.au/resource/mortality-among-people-who-use-illicit-drugs-toolkit-classifying-major-causes-death

O Brien SM; Black E; Degenhardt LJ; Roxburgh AD; Campbell G; de Graaff B; Fetherston J; Jenkinson R; Kinner S; Moon C; White N, 2007, Australian Drug Trends 2006: Findings from the Illicit Drug Reporting System (IDRS), National Drug and Alcohol Research Centre, Sydney, NSW, http://ndarc.med.unsw.edu.au/resource/australian-drug-trends-2006-findings-illicit-drug-reporting-system-idrs

Black E; Roxburgh AD; Degenhardt LJ, 2007, NSW Drug Trends 2006: Findings from the Illicit Drug Reporting System (IDRS), National Drug & Alcohol Research Centre, Randwick, NSW

Gibson AE; Larance BK; Roxburgh AD; Degenhardt LJ; Black E, 2007, The extent of diversion of fentanyl for non-medical puposes in Australia: What do we know?, National Drug & Alcohol Research Centre, Randwick, NSW

Roxburgh AD; Degenhardt LJ; Breen CL; Barker B, 2003, NSW Drug Trends 2002: Findings from the Illicit Drug Reporting System (IDRS, National Drug & Alcohol Research Centre, Randwick, NSW

Breen CL; Degenhardt LJ; Roxburgh AD; Bruno R; Fry C, 2003, The impact of changes in the availablility of publicly subsidised 10 Temazepam gel caps in Australia, National Drug & Alcohol Research Centre, Randwick, NSW

Journal articles

Bartlett M; Jauncey M; Brett J; Wood W; Roxburgh A, 2025, 'Response to “Do We Need On-Site Drug Analysis Within Supervised Injecting Facilities?”', Drug and Alcohol Review, 44, pp. 1296 - 1297, http://dx.doi.org/10.1111/dar.14067

Stewart AC; Hickman M; Agius PA; Scott N; Stone J; Roxburgh A; O'Keefe D; Higgs P; Kerr T; Stoové MA; Thompson A; Crawford S; Norman J; Vella-Horne D; Lloyd Z; Clark N; Maher L; Dietze P, 2025, 'Supervised Injecting Room Cohort Study (SIRX): study protocol', BMJ Open, 15, pp. e091337, http://dx.doi.org/10.1136/bmjopen-2024-091337

Roxburgh A; Van Buskirk J; Roberts DM; Stoove M; Raubenheimer J; Dietze P; Reid S; Haber PS; Day CA, 2025, 'Treatment completion among Australians attending publicly-funded specialist alcohol and other drug treatment services', Journal of Substance Use and Addiction Treatment, 169, http://dx.doi.org/10.1016/j.josat.2024.209588

Mammoliti E; Nielsen S; Roxburgh A, 2025, 'A Scoping Review of the Emergence of Novel Synthetic Opioids in Australian Drug Markets: What Does This Mean for Harm Reduction Responses?', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.14079

Lloyd Z; Colledge-Frisby S; Taylor N; Livingston M; Jauncey M; Roxburgh A, 2025, 'Analyses Updated to 2022–23 on Australian Attitudes Towards Supervised Injecting Facilities', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.14089

Schumann JL; Dwyer J; Brown JA; Jauncey M; Roxburgh A, 2025, 'Identification of nitazene-related deaths in Australia: How do we make it accurate and timely?', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.14028

Abdelsalam S; Agius PA; Sacks-Davis R; Roxburgh A; Livingston M; Maher L; Hickman M; Dietze P, 2024, 'Characteristics of attrition within the SuperMIX cohort of people who inject drugs: a multiple event discrete-time survival analysis', BMC Medical Research Methodology, 24, http://dx.doi.org/10.1186/s12874-024-02377-1

Lloyd Z; Colledge-Frisby S; Taylor N; Livingston M; Jauncey M; Roxburgh A, 2024, 'Changes in Australians' attitudes towards supervised injecting facilities', Drug and Alcohol Review, 43, pp. 1892 - 1904, http://dx.doi.org/10.1111/dar.13937

Stronach O; Dietze P; Livingston M; Roxburgh A, 2024, '20-year trends in Australian methamphetamine-related deaths, 2001–2020', International Journal of Drug Policy, 131, http://dx.doi.org/10.1016/j.drugpo.2024.104548

Hocknull K; Geiger B; Bartlett M; Colledge-Frisby S; Shand F; Day CA; Jauncey M; Roxburgh A, 2024, 'Improving assessment and management of suicide risk among people who inject drugs: A mixed methods study conducted at the Medically Supervised Injecting Centre, Sydney', Drug and Alcohol Review, 43, pp. 1597 - 1606, http://dx.doi.org/10.1111/dar.13900

Page R; Jauncey M; Brett J; Wood W; Roxburgh A, 2024, 'The role of on-site drug analysis within supervised injecting facilities: A case presentation of an adverse event highlighting need', Drug and Alcohol Review, 43, pp. 1592 - 1596, http://dx.doi.org/10.1111/dar.13909

Salomon A; Bartlett M; Chenery M; Jauncey M; Roxburgh A, 2023, 'Outrage and algorithms: Shifting drug-related stigma in a digital world', International Journal of Drug Policy, 122, http://dx.doi.org/10.1016/j.drugpo.2023.104224

Roxburgh A; Livingston M; Dietze P; Nielsen S; Cogger S; Bartlett M; Day C; Latimer J; Jauncey M; Clark N, 2023, 'The impact of COVID-19 public health measures on attendance and overdose at supervised injecting facilities in Australia', Public Health, 224, pp. 90 - 97, http://dx.doi.org/10.1016/j.puhe.2023.08.019

Roxburgh A; Nielsen S, 2022, 'Twenty-year trends in pharmaceutical fentanyl and illicit fentanyl deaths, Australia 2001–2021', International Journal of Drug Policy, 109, http://dx.doi.org/10.1016/j.drugpo.2022.103854

Day CA; Salmon A; Jauncey M; Bartlett M; Roxburgh A, 2022, 'Twenty-one years at the Uniting Medically Supervised Injecting Centre, Sydney: addressing the remaining questions', Medical Journal of Australia, 217, pp. 385 - 387, http://dx.doi.org/10.5694/mja2.51716

Jauncey M; Bartlett M; Roxburgh A, 2022, 'Commentary on Skulberg et al.: Naloxone administration—finding the balance', Addiction, 117, pp. 1668 - 1669, http://dx.doi.org/10.1111/add.15887

Stam NC; Cogger S; Schumann JL; Weeks A; Roxburgh A; Dietze PM; Clark N, 2022, 'The onset and severity of acute opioid toxicity in heroin overdose cases: a retrospective cohort study at a supervised injecting facility in Melbourne, Australia', Clinical Toxicology, 60, pp. 1227 - 1234, http://dx.doi.org/10.1080/15563650.2022.2126371

Roxburgh A; Jauncey M; Day C; Bartlett M; Cogger S; Dietze P; Nielsen S; Latimer J; Clark N, 2021, 'Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia', Harm Reduction Journal, 18, http://dx.doi.org/10.1186/s12954-021-00471-x

Roxburgh A; Sam B; Kriikku P; Mounteney J; Castanera A; Dias M; Giraudon I, 2021, 'Trends in MDMA-related mortality across four countries', Addiction, 116, pp. 3094 - 3103, http://dx.doi.org/10.1111/add.15493

Haber PS; Riordan BC; Winter DT; Barrett L; Saunders J; Hides L; Gullo M; Manning V; Day CA; Bonomo Y; Burns L; Assan R; Curry K; Mooney-Somers J; Demirkol A; Monds L; McDonough M; Baillie AJ; Clark P; Ritter A; Quinn C; Cunningham J; Lintzeris N; Rombouts S; Savic M; Norman A; Reid S; Hutchinson D; Zheng C; Iese Y; Black N; Draper B; Ridley N; Gowing L; Stapinski L; Taye B; Lancaster K; Stjepanović D; Kay-Lambkin F; Jamshidi N; Lubman D; Pastor A; White N; Wilson S; Jaworski AL; Memedovic S; Logge W; Mills K; Seear K; Freeburn B; Lea T; Withall A; Marel C; Boffa J; Roxburgh A; Purcell-Khodr G; Doyle M; Conigrave K; Teesson M; Butler K; Connor J; Morley KC, 2021, 'New Australian guidelines for the treatment of alcohol problems: an overview of recommendations', Medical Journal of Australia, 215, pp. S3 - S32, http://dx.doi.org/10.5694/mja2.51254

Day CA; Bonomo Y; Burns L; Assan R; Curry K; Mooney--Somers J; Demirkol A; Monds L; Reid S; Norman A; Hutchinson D; Zheng C; Iese Y; Black N; Memedovic S; Draper BM; Ridley N; White N; Pastor A; Wilson S; Freeburn B; Boffa JD; Purcell-Khodr G; Doyle M; Jaworski AL; Lea T; Roxburgh A; Logge W; Withall A; Conigrave KM, 2021, 'Providing appropriate treatment and care to people with alcohol problems: a summary for key specific populations', MEDICAL JOURNAL OF AUSTRALIA, 215, pp. S21 - S27

Tran V; Reid SE; Roxburgh A; Day CA, 2021, 'Assessing drug consumption rooms and longer term (5 year) impacts on community and clients', Risk Management and Healthcare Policy, 14, pp. 4639 - 4647, http://dx.doi.org/10.2147/RMHP.S244720

Roxburgh A; Lappin J, 2020, 'MDMA-related deaths in Australia 2000 to 2018', International Journal of Drug Policy, 76, http://dx.doi.org/10.1016/j.drugpo.2019.102630

Roxburgh A; Hall WD; Gisev N; Degenhardt L, 2019, 'Characteristics and circumstances of heroin and pharmaceutical opioid overdose deaths: Comparison across opioids', Drug and Alcohol Dependence, 205, http://dx.doi.org/10.1016/j.drugalcdep.2019.06.035

Praeger R; Roxburgh A; Passey M; Mooney-Somers J, 2019, 'The prevalence and factors associated with smoking among lesbian and bisexual women: Analysis of the Australian National Drug Strategy Household Survey', International Journal of Drug Policy, 70, pp. 54 - 60, http://dx.doi.org/10.1016/j.drugpo.2019.03.028

Sutherland R; Peacock A; Roxburgh A; Barratt MJ; Burns L; Bruno R; Peacock A, 2018, 'Typology of new psychoactive substance use among the general Australian population', Drug and Alcohol Dependence, 188, pp. 126 - 134, http://dx.doi.org/10.1016/j.drugalcdep.2018.03.034

Roxburgh A; Pilgrim JL; Hall WD; Burns L; Degenhardt L, 2018, 'Accurate identification of opioid overdose deaths using coronial data', Forensic Science International, 287, pp. 40 - 46, http://dx.doi.org/10.1016/j.forsciint.2018.03.032

Gisev N; Larance B; Cama E; Nielsen S; Roxburgh A; Bruno R; Degenhardt L, 2018, 'A nationwide study of the extent and factors associated with fentanyl use in Australia', Research in Social and Administrative Pharmacy, 14, pp. 303 - 308, http://dx.doi.org/10.1016/j.sapharm.2017.04.002

Roxburgh A; Hall WD; Dobbins T; Gisev N; Burns L; Pearson S; Degenhardt L, 2017, 'Trends in heroin and pharmaceutical opioid overdose deaths in Australia', Drug and Alcohol Dependence, 179, pp. 291 - 298, http://dx.doi.org/10.1016/j.drugalcdep.2017.07.018

Roxburgh A; Darke ; Salmon ; Dobbins ; Jauncey , 2017, 'Frequency and severity of non-fatal opioid overdoses among clients attending the Sydney Medically Supervised Injecting Centre', Drug and Alcohol Dependence, 176, pp. 126 - 132, http://dx.doi.org/10.1016/j.drugalcdep.2017.02.027

Van Buskirk J; Bruno R; Dobbins T; Breen C; Burns L; Naicker S; Roxburgh A, 2017, 'The recovery of online drug markets following law enforcement and other disruptions', Drug and Alcohol Dependence, 173, pp. 159 - 162, http://dx.doi.org/10.1016/j.drugalcdep.2017.01.004

Degenhardt L; Sara G; McKetin R; Roxburgh A; Dobbins T; Farrell M; Burns L; Hall WD, 2017, 'Crystalline methamphetamine use and methamphetamine-related harms in Australia', Drug and Alcohol Review, 36, pp. 160 - 170, http://dx.doi.org/10.1111/dar.12426

Van Buskirk J; Roxburgh A; Bruno R; Naicker S; Lenton S; Sutherland R; Whittaker E; Sindicich N; Matthews A; Butler K; Burns L, 2017, 'Corrigendum to “Characterising dark net marketplace purchasers in a sample of regular psychostimulant users” [International Journal of Drug Policy 35 (2016) 32–37]((S0955395916000335)(10.1016/j.drugpo.2016.01.010))', International Journal of Drug Policy, 39, pp. 140, http://dx.doi.org/10.1016/j.drugpo.2016.11.001

Roxburgh AD; Burns L, 2017, 'Accidental drug-induced deaths due to opioids in Australia, 2013', NIDIP, http://www.drugtrends.org.au/reports/nidip-opioid-deaths-2013/

Roxburgh AD; Burns L, 2017, 'Cocaine and methamphetamine related drug-induced deaths in Australia, 2013', NIDIP Bulletin, pp. 1 - 5

Roxburgh AD; Breen C, 2017, 'Drug-related hospital stays in Australia, 1993-2015', NIDIP Bulletin, pp. 1 - 16

Roxburgh AD; Van Buskirk J; Burns L; Bruno R, 2017, 'Drugs and the Internet', Drugs and New Technologies (DNet) Bulletin, pp. 1 - 12, https://dlnstorage.blob.core.windows.net/drt101/1893/dnet-8th-buletin_website.pdf

Roxburgh AD; Van Buskirk J; Burns L; Bruno R, 2017, 'Drugs and the Internet', Drugs and New Technologies (DNet) Bulletin, pp. 1 - 11, https://dlnstorage.blob.core.windows.net/drt101/1915/dnet-9th-bulletin_final.pdf

Roxburgh AD; O'Donnell C; Burns L, 2017, 'Use and knowledge of darknet markets among people who regularly use stimulants', EDRS Drug Trends Bulletin, pp. 1 - 4, https://ndarc.med.unsw.edu.au/resource/edrs-drug-trends-bulletin-december-2017-use-and-knowledge-darknet-markets-among-people-who

Lappin JM; Roxburgh A; Kaye S; Chalmers J; Sara G; Dobbins T; Burns L; Farrell M, 2016, 'Increased prevalence of self-reported psychotic illness predicted by crystal methamphetamine use: Evidence from a high-risk population', International Journal of Drug Policy, 38, pp. 16 - 20, http://dx.doi.org/10.1016/j.drugpo.2016.10.018

Van Buskirk J; Roxburgh A; Bruno R; Naicker S; Lenton S; Sutherland R; Whittaker E; Sindicich N; Matthews A; Butler K; Burns L, 2016, 'Characterising dark net marketplace purchasers in a sample of regular psychostimulant users', International Journal of Drug Policy, 35, pp. 32 - 37, http://dx.doi.org/10.1016/j.drugpo.2016.01.010

Van Buskirk J; Naicker S; Roxburgh A; Bruno R; Burns L, 2016, 'Who sells what? Country specific differences in substance availability on the Agora cryptomarket', International Journal of Drug Policy, 35, pp. 16 - 23, http://dx.doi.org/10.1016/j.drugpo.2016.07.004

Back to profile page